IL112256A0 - Topical treatment of ocular photophobia - Google Patents

Topical treatment of ocular photophobia

Info

Publication number
IL112256A0
IL112256A0 IL11225695A IL11225695A IL112256A0 IL 112256 A0 IL112256 A0 IL 112256A0 IL 11225695 A IL11225695 A IL 11225695A IL 11225695 A IL11225695 A IL 11225695A IL 112256 A0 IL112256 A0 IL 112256A0
Authority
IL
Israel
Prior art keywords
topical treatment
ocular photophobia
photophobia
ocular
topical
Prior art date
Application number
IL11225695A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL112256A0 publication Critical patent/IL112256A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11225695A 1994-01-11 1995-01-05 Topical treatment of ocular photophobia IL112256A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18017894A 1994-01-11 1994-01-11

Publications (1)

Publication Number Publication Date
IL112256A0 true IL112256A0 (en) 1995-03-30

Family

ID=22659506

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11225695A IL112256A0 (en) 1994-01-11 1995-01-05 Topical treatment of ocular photophobia

Country Status (4)

Country Link
AU (1) AU1249395A (xx)
IL (1) IL112256A0 (xx)
WO (1) WO1995018604A1 (xx)
ZA (1) ZA95134B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2332271C (en) * 1998-05-15 2008-08-05 Wakamoto Pharmaceutical Co., Ltd. Selective cyclooxygenase-2 anti-inflammatory eye drops
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
CN102647971B (zh) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 用于包含美洛昔康的组合物的容器
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
WO2020212760A2 (en) * 2019-04-18 2020-10-22 Azura Ophthalmics Ltd. Compounds and methods for the treatment of ocular disorders

Also Published As

Publication number Publication date
ZA95134B (en) 1995-07-11
WO1995018604A1 (en) 1995-07-13
AU1249395A (en) 1995-08-01

Similar Documents

Publication Publication Date Title
ZA96740B (en) Skin treatment composition
AU7905894A (en) Treatment of poultry
GB9310241D0 (en) Cosmetic treatment of substrates
ZA952356B (en) Skin treatment composition
GB9324773D0 (en) Treatment of cellulose
ZA95134B (en) Topical treatment of ocular photophobia
AU2068295A (en) Skin treatment composition
AU5340594A (en) Skin treatment
IL104755A0 (en) Treatment of glaucoma
AU7565894A (en) Acupuncture treatment of common baldness
GB9211736D0 (en) Allergic treatment
GB9510162D0 (en) Compositions for the treatment of skin conditions
GB9419048D0 (en) Treatment of muscular disorders
ZA952120B (en) Skin treatment composition
AU3430795A (en) Treatment of fabrics
GB9218773D0 (en) Skin treatment
ZA97253B (en) Topical compositions for the treatment of skin diseases
GB9407335D0 (en) Method of treatment
AU5397994A (en) Treatment of skin disorders
ZA957904B (en) Treatment of water
GB9507482D0 (en) Skin treatment composition
GB9414652D0 (en) Method of treatment
GB9310578D0 (en) Treatment of baldness
GB9310611D0 (en) Skin treatment
GB9522475D0 (en) Treatment of raynauds phenomenon